Type of Spiritual Experience
A description of the experience
Pegylated interferon alfa-2b is a treatment for hepatitis C developed by Schering-Plough, brand name is PegIntron. It was approved in January 2001.
It has also been approved as treatment for melanoma [skin cancer] with nodal involvement after surgical resection, under the brand name Sylatron in April 2011.
PEG-interferon alpha is a pegylated interferon composed of 165 amino acids. The PEG (polyethylene glycol) protects the molecule from proteolytic breakdown and increases the biological half-life of the interferon protein
On Jan, 17, 2017 9,711 people reported to have side effects when taking Pegintron. Among them, 23 people (0.24%) have Hallucinations
On Jan, 15, 2017 9,711 people reported to have side effects when taking Pegintron. Among them, 40 people (0.41%) have Death
The source of the experienceeHealthme
Concepts, symbols and science items
Activities and commonsteps
Hepatitis virus infection
Viral infection - Interferon drugs